Effient Oral Tablet 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Effient: Oral tablet (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_16383.JPG
Effient 10mg Tab
Eli Lilly and Co
Pill Identification: LOGO 10  |  5123
Drug Image file DrugItem_16384.JPG
Effient 10mg Tab
Eli Lilly and Co
Pill Identification: LOGO 10  |  5123
Drug Image file DrugItem_11971.JPG
Effient 10mg Tab
Eli Lilly and Co
Pill Identification: 4759  |  10 MG

What is this Medicine?

PRASUGREL (PRA soo grel) helps to prevent blood clots. This medicine is used to prevent heart attack, stroke, or other vascular events in people who are at high risk.

CVS Pharmacy Patient Statistics for Effient: Oral tablet(10mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Effient 10mg Tablet

NDC: 000025123
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Acute Myocardial Infarction, Percutaneous Coronary Intervention (PCI), Arterial Thromboembolism Prophylaxis, Unstable Angina

Storage Information
Store in original container
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Effient 10mg Tablet
Drug Image file DrugItem_16383.JPG
Eli Lilly and Co
Pill Identification: LOGO 10  |  5123
Shape: hexagonal (6-sided)
Color: beige

Reported Side Effects for Effient 10mg Tablet

Low White Blood Cells Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Angioedema Incidence:
0.1%*
Severity: SEVERE
Onset: RAPID
Bleeding In The Abdomen Incidence:
0.3%*
Severity: SEVERE
Onset: DELAYED
Low Platelet Count Incidence:
0.3%*
Severity: MODERATE
Onset: DELAYED
Bruise Incidence:
0.5%*
Severity: MODERATE
Onset: EARLY
Coughing Up Blood Incidence:
0.6%*
Severity: MODERATE
Onset: DELAYED
Bleeding In The Brain Incidence:
1.4%*
Severity: SEVERE
Onset: DELAYED
Intestinal Bleeding Incidence:
1.5%*
Severity: SEVERE
Onset: DELAYED
Secondary Malignancy Incidence:
1.6%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
2.2%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
2.3%*
Severity: MILD
Onset: EARLY
Bleeding Incidence:
2.4%*
Severity: MODERATE
Onset: EARLY
Fever Incidence:
2.7%*
Severity: MILD
Onset: EARLY
Fluid Retention Incidence:
2.7%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
2.8%*
Severity: MILD
Onset: EARLY
Low White Blood Cell Counts Incidence:
2.8%*
Severity: MODERATE
Onset: DELAYED
Irregular Heart Beat Incidence:
2.9%*
Severity: SEVERE
Onset: EARLY
Slow Heart Beat Incidence:
2.9%*
Severity: SEVERE
Onset: RAPID
Chest Pain Incidence:
3.1%*
Severity: MODERATE
Onset: EARLY
Tired Incidence:
3.7%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
3.9%*
Severity: MODERATE
Onset: RAPID
Cough Incidence:
3.9%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
4.1%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
4.6%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
4.9%*
Severity: MODERATE
Onset: EARLY
Back Pain Incidence:
5.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
5.5%*
Severity: MILD
Onset: EARLY
Nose Bleed Incidence:
6.2%*
Severity: MILD
Onset: DELAYED
Increased Blood Fats Incidence:
7.0%*
Severity: MODERATE
Onset: DELAYED
High Cholesterol Incidence:
7.0%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
7.5%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Effient

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.